Sign inJoin waitlistJoin the waitlist

Kathryn Stephenson

HVTN CRS Leader · Beth Israel Deaconess Medical Center

Credentials: · · · · ·

History

Beth Israel Deaconess Medical Center
Present

Infectious Disease
2008–2010
Internal Medicine
New York Presbyterian Hospital
2005–2008
Columbia University
New York University
2001–2005

Research

Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine
New England Journal of Medicine · 2021 · 885 citations
Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys
Nature · 2013 · 559 citations
Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys
Science · 2016 · 401 citations

Dan Barouch
50 papers
SW
Stephen Walsh
13 papers
NM
Nelson Michael
11 papers
JC
Jessica Curran
8 papers
Magdalena Sobieszczyk
8 papers
MR
Merlin Robb
8 papers
Jim Kublin
7 papers
Juliana McElrath
6 papers
Lawrence Corey
6 papers
MD
Macaya Douoguih
6 papers
FT
Frank Tomaka
5 papers
KJ
Kate Jaegle
5 papers

Grants

IP24-045, A Prospective Observational Study of Respiratory Virus Epidemiology in the Greater Boston Area
NCIRD · U01
Contact PI · $11.3M · Beth Israel Deaconess Medical Center
2024–2029
Diversity of Immune Responses Elicited by HIV Vaccines
National Institute of Allergy and Infectious Diseases · K23
Contact PI · $817.6K · Beth Israel Deaconess Medical Center
2014–2020
Measurement of Antibody Epitope Signatures by Peptide Microarrays to Determine Recency of HIV Infection
National Institute of Allergy and Infectious Diseases · R21
Contact PI · $473.7K · Beth Israel Deaconess Medical Center
2016–2019

Clinical trials

Trial of the Safety and Immunogenicity of an Oral, Replicating Ad26 Vectored HIV-1 Vaccine
Study chair · Completed · Phase 1
International AIDS Vaccine Initiative
2015–2016